157 related articles for article (PubMed ID: 6111350)
21. Prodrugs of peptides. 19. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by N-acyloxymethylation and other means.
Møss J; Bundgaard H
Acta Pharm Nord; 1992; 4(4):301-8. PubMed ID: 1363462
[TBL] [Abstract][Full Text] [Related]
22. Purification and characterization of L-pyrrolidonecarboxylate peptidase from Bacillus amyloiliquefaciens.
Tsuru D; Fujiwara K; Kado K
J Biochem; 1978 Aug; 84(2):467-76. PubMed ID: 29893
[TBL] [Abstract][Full Text] [Related]
23. [Membrane-bound alanine aminopeptidase from Acinetobacter calcoaceticus. 4. Amino acid chloromethyl ketones as pH-dependent, substrate-derived inhibitors of cysteine protease].
Jahreis G; Aurich H
Biomed Biochim Acta; 1991; 50(9):1043-9. PubMed ID: 1686704
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of leucyl aminopeptidase and pyroglutamyl aminopeptidase from human skeletal muscle.
Mantle D; Lauffart B; Gibson A
Clin Chim Acta; 1991 Feb; 197(1):35-45. PubMed ID: 1675162
[TBL] [Abstract][Full Text] [Related]
25. Insect chymotrypsins: chloromethyl ketone inactivation and substrate specificity relative to possible coevolutional adaptation of insects and plants.
Lopes AR; Sato PM; Terra WR
Arch Insect Biochem Physiol; 2009 Mar; 70(3):188-203. PubMed ID: 19194984
[TBL] [Abstract][Full Text] [Related]
26. Purification and properties of the pyrrolidonecarboxylate peptidase of Streptococcus faecium.
Sullivan JJ; Muchnicky EE; Davidson BE; Jago GR
Aust J Biol Sci; 1977 Dec; 30(6):543-52. PubMed ID: 26327
[TBL] [Abstract][Full Text] [Related]
27. Rapid inactivation and phosphorylation of pyroglutamyl peptidase II in Y-79 human retinoblastoma cells after exposure to phorbol ester.
Suen CS; Wilk S
Endocrinology; 1990 Dec; 127(6):3038-46. PubMed ID: 1979029
[TBL] [Abstract][Full Text] [Related]
28. The mechanism of aubstrate eecognition of pyroglutamyl-peptidase I from Bacillus amyloliquefaciens as determined by X-ray crystallography and site-directed mutagenesis.
Ito K; Inoue T; Takahashi T; Huang HS; Esumi T; Hatakeyama S; Tanaka N; Nakamura KT; Yoshimoto T
J Biol Chem; 2001 May; 276(21):18557-62. PubMed ID: 11359794
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of calpain I and calpain II by specificity-oriented tripeptidyl chloromethyl ketones.
Sasaki T; Kikuchi T; Fukui I; Murachi T
J Biochem; 1986 Jan; 99(1):173-9. PubMed ID: 3007444
[TBL] [Abstract][Full Text] [Related]
30. Hydrolysis of synthetic substrate, L-pyroglutamyl p-nitroanilide is catalyzed solely by pyroglutamyl aminopeptidase I in rat liver cytosol.
Abe K; Watanabe N; Kosaka T; Yamada M; Tokui T; Ikeda T
Biol Pharm Bull; 2003 Nov; 26(11):1528-33. PubMed ID: 14600395
[TBL] [Abstract][Full Text] [Related]
31. Pyroglutamyl peptidase: an overview of the three known enzymatic forms.
Cummins PM; O'Connor B
Biochim Biophys Acta; 1998 Dec; 1429(1):1-17. PubMed ID: 9920379
[TBL] [Abstract][Full Text] [Related]
32. Influence of dietary supplementation with olive oil on pyroglutamyl-beta-naphthylamide hydrolysing activity in serum and different tissues of mice.
Martínez JM; Ramírez MJ; Prieto I; Alba F; Ramírez M
Folia Biol (Praha); 1998; 44(6):213-6. PubMed ID: 10730865
[TBL] [Abstract][Full Text] [Related]
33. N alpha-formyl-norleucyl-leucyl-phenylalanyl chloromethylketone. A possible covalent agonist of the N alpha-formyl-methionyl-peptide receptor.
Showell HJ; Mackin WM; Becker EL; Muthukumarasway N; Day AR; Freer R
Mol Cell Biochem; 1981 Dec; 41():19-25. PubMed ID: 6276716
[TBL] [Abstract][Full Text] [Related]
34. Assay of pyroglutamyl aminopeptidase by high-performance liquid chromatography and its use in peptide sequencing.
Martini F; Bossa F; Barra D
Peptides; 1985; 6 Suppl 3():103-5. PubMed ID: 2870471
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of interferons: halomethyl ketone derivatives of phenylalanine as affinity labels.
McCray JW; Weil R
Proc Natl Acad Sci U S A; 1982 Aug; 79(16):4829-33. PubMed ID: 6956895
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of pyroglutamyl peptidase I from Bacillus amyloliquefaciens reveals a new structure for a cysteine protease.
Odagaki Y; Hayashi A; Okada K; Hirotsu K; Kabashima T; Ito K; Yoshimoto T; Tsuru D; Sato M; Clardy J
Structure; 1999 Apr; 7(4):399-411. PubMed ID: 10196127
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, crystallization and properties of acetyl phenylalanyl lysine chloromethyl ketone: a potential inhibitor of serine proteases.
Murthy VV; Laster T
Experientia; 1980 Apr; 36(4):397-8. PubMed ID: 6991271
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of the free and Peptide forms of pyroglutamic acid in plasma from the portal blood of rats that had ingested a wheat gluten hydrolysate containing pyroglutamyl peptides.
Higaki-Sato N; Sato K; Inoue N; Nawa Y; Kido Y; Nakabou Y; Hashimoto K; Nakamura Y; Ohtsuki K
J Agric Food Chem; 2006 Sep; 54(19):6984-8. PubMed ID: 16968052
[TBL] [Abstract][Full Text] [Related]
39. Evidence for an active-center cysteine in the SH-proteinase alpha-clostripain through use of N-tosyl-L-lysine chloromethyl ketone.
Gilles AM; Keil B
FEBS Lett; 1984 Jul; 173(1):58-62. PubMed ID: 6378663
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol and steroids action on aminopeptidases.
Martinez JM; Prieto I; Ramirez MJ; Alba F; Ramirez M
Biochem Soc Trans; 1997 Feb; 25(1):113S. PubMed ID: 9057011
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
